NCT04330599 Longitudinal Population-based Observational Study of COVID-19 in the UK Population
| NCT ID | NCT04330599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Queen Mary University of London |
| Condition | COVID-19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 13,000 participants |
| Start Date | 2020-04-27 |
| Primary Completion | 2026-04-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 13,000 participants in total. It began in 2020-04-27 with a primary completion date of 2026-04-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
COVIDENCE UK is a population-based observational longitudinal study that has the following objectives: 1. To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population 2. To characterise the natural history of COVID-19 in the UK population 3. To evaluate the impact of COVID-19 on the physical and mental health of the UK population 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in COVIDENCE as comparison or control data for trial participants who have been randomised to receive one or more interventions.
Eligibility Criteria
Inclusion Criteria: * UK resident * Age ≥16 years Exclusion Criteria: none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04330599 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04330599 currently recruiting?
Yes, NCT04330599 is actively recruiting participants. Contact the research team at a.martineau@qmul.ac.uk for enrollment information.
Where is the NCT04330599 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT04330599 clinical trial?
NCT04330599 is sponsored by Queen Mary University of London. The trial plans to enroll 13,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.